News & Articles

25

Articles Filter

Explore by Field
Flow Cytometry / Cell Counting
Explore by Company
Explore by Content

Search

Selected Filters:









Editorial Article

What next for CRISPR after first therapeutic approvals?

As we celebrate the first regulatory approval of a gene-editing based therapeutic, Casgevy™, for the treatment of sickle cell disease and transfusion-dependent β-thalassemia, we consider the gene-editing challenges that must be overcome before CRISPR gene-editing technology becomes a common treatment modality